[Calcium antagonists in congestive heart failure].
Barbieri
L
L
Divisione di Cardiologia, Ospedale Maggiore, Università degli Studi, Trieste.
Mestroni
L
L
Camerini
F
F
D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy; D004110:Diltiazem / Q000494:pharmacology / Q000627:therapeutic use; D015736:Felodipine; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009529:Nicardipine / Q000494:pharmacology / Q000627:therapeutic use; D009543:Nifedipine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D015737:Nisoldipine; D009568:Nitrendipine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D015737:Nisoldipine; D009568:Nitrendipine; D014700:Verapamil; D009529:Nicardipine; D004110:Diltiazem; D009543:Nifedipine; D015736:Felodipine
I calcioantagonisti nello scompenso cardiaco congestizio.